32 minVendor WorkshopOnline

Optimizing AI Utilization in Prostate Cancer Screening

About this session

Artificial intelligence (AI) has emerged as a  tool in the detection and diagnosis of prostate cancer, leveraging machine learning (ML) and deep learning (DL) algorithms to enhance accuracy and efficiency. These AI systems have been applied to prostate MRI to reduce inter-reader variability and improve lesion detection as well as monitor patients on active surveillance (AS) for prostate cancer.

Oncology
Achieving operational excellence
Vendor Workshop RSNA 2024
RSNA 2024

Mukesh Harisinghani
MD, Professor, Massachusetts General Hospital, Boston, United States
Speaker

Related Product and Topics

Prostate MRI

New certainty in prostate cancer assessment

AI-Rad Companion

AI-Rad Companion automatically performs measurements and prepares results in the form of clinical images and reports.

Are you interested?

Want to know more about RSNA 2024?

Learn more

Want to know more about a product or talk to a sales representative?


Get in touch

Do you find this page interesting? Share the information with peers.